Drug Imports From Canada Allowed to Keep Prescription Costs Down

Sept. 25, 2020, 12:24 AM

The U.S. will import some medications from Canada in order to keep prescription prices down, the Food and Drug Administration announced Thursday.

The final rule allows states, tribes, pharmacists, and wholesalers to submit plans to the FDA to import medications provided they can demonstrate the moves would save patients money. Import plan sponsors must also show the medications being brought in pose no threats to patient safety.

The rule will take effect 60 days after it is published in the Federal Register.

In separate guidance, the FDA detailed requirements to import biological products. The products must be approved by the FDA and be manufactured and approved for sale in other countries.

“Today’s action is an important part of FDA’s priorities to promote choice and competition. The Safe Importation Action Plan aims to clearly describe procedures to import drugs that would lower prices and improve access while also maintaining the high quality and safety Americans expect and deserve,” FDA Commissioner Stephen M. Hahn said in a statement.

To contact the reporter on this story: Andrew Childers in Washington at achilders@bloomberglaw.com

To contact the editor responsible for this story: Fawn Johnson at fjohnson@bloomberglaw.com

To read more articles log in.

Learn more about a Bloomberg Law subscription.